Skip to main content

MoneyWorks4Me

An increase of about 84.21% to Rs. 2676.35 millions in the topline was observed for the quarter ended September 2026. The topline stood at Rs. 1452.91 millions during the similar quarter previous year.The Profit  for the quarter ended September 2026 of  Rs. 188.26  millions  grew by 93.46% from Rs. 97.31 millions.Operating profit for the quarter ended September 2026 rose to 426.02 millions as compared to 223.34 millions of corresponding quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 2676.35 1452.91 84.21 4958.83 2651.46 87.02 6391.21 4562.68 40.08
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 426.02 223.34 90.75 753.78 393.25 91.68 947.94 550.97 72.05
Interest 87.76 77.31 13.52 173.94 142.63 21.95 392.98 223.77 75.62
PBDT 338.26 146.03 131.64 579.84 250.62 131.36 554.96 327.20 69.61
Depreciation 39.23 15.98 145.49 74.94 30.17 148.39 79.14 44.49 77.88
PBT 299.03 130.05 129.93 504.90 220.45 129.03 475.82 282.71 68.31
TAX 110.77 32.74 238.33 184.97 55.49 233.34 143.75 74.63 92.62
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 188.26 97.31 93.46 319.93 164.96 93.94 332.07 208.08 59.59
Equity 169.00 141.65 19.31 169.00 141.65 19.31 54.73 47.22 15.90
PBIDTM(%) 15.92 15.37 3.55 15.20 14.83 2.49 14.83 12.08 22.83
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..